Journal article
Effects of Clonidine on the Cardiovascular, Renal, and Inflammatory Responses to Experimental Bacteremia
P Calzavacca, LC Booth, YR Lankadeva, SR Bailey, LM Burrell, M Bailey, R Bellomo, CN May
Shock | LIPPINCOTT WILLIAMS & WILKINS | Published : 2019
Abstract
Introduction:Supra-clinical doses of clonidine appear beneficial in experimental sepsis, but there is limited understanding of the effects of clonidine at clinically relevant doses.Methods:In conscious sheep, with implanted renal and pulmonary artery flow probes, sepsis was induced by infusion of live Escherichia coli. At 24 h, a high clinical dose of clonidine (HCDC) [1.0 μg/kg/h], a low clinical dose of clonidine (LCDC) [0.25 μg/kg/h] or vehicle, was infused for 8 h.Results:Animals developed hyperdynamic, hypotensive sepsis with acute kidney injury. The HCDC decreased heart rate (153 ± 6 to 119 ± 7 bpm) and cardiac output (5.6 ± 0.4 to 5.0 ± 0.4 L/min), with no reduction in mean arterial p..
View full abstractRelated Projects (1)
Grants
Awarded by Jack Brockhoff Foundation
Funding Acknowledgements
7 This study was supported by a grant from the National Health and Medical Research Council of Australia (NHMRC, 1009280), and by funding from the Victorian Government Operational Infrastructure Support Grant and the Jack Brockhoff Foundation. PC was supported by an international student scholarship from Melbourne University. YRL was supported by Postdoctoral Fellowship from the National Heart Foundation of Australia (NHF, 100869).